These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9398022)

  • 21. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
    Gao ZH
    J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
    [No Abstract]   [Full Text] [Related]  

  • 22. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma.
    Plessier A; Codes L; Consigny Y; Sommacale D; Dondero F; Cortes A; Degos F; Brillet PY; Vilgrain V; Paradis V; Belghiti J; Durand F
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S86-90. PubMed ID: 14762846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular prognostication of liver cancer: end of the beginning.
    Thorgeirsson SS; Lee JS; Grisham JW
    J Hepatol; 2006 Apr; 44(4):798-805. PubMed ID: 16488507
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
    Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
    Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation.
    Roberts JP
    Liver Transpl; 2005 Nov; (11 Suppl 2):S45-6. PubMed ID: 16237702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of metastatic cutaneous nodules of recurrent hepatocellular carcinoma].
    Cho M; Choi CS; Seo GS; Kim TH; Choi SC; Yun KJ; Kim HC
    Korean J Hepatol; 2007 Jun; 13(2):234-8. PubMed ID: 17585197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent needle-tract metastases of hepatocellular carcinoma following fine-needle aspiration.
    Pavan C; Parisi A; Girelli D
    Intern Med J; 2007 Feb; 37(2):134-6. PubMed ID: 17229260
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
    Pérez-Saborido B; de los Galanes SJ; Menéu-Díaz JC; Romero CJ; Elola-Olaso AM; Suárez YF; Valencia VB; Moreno-González E
    Transplant Proc; 2007 Sep; 39(7):2304-7. PubMed ID: 17889172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
    Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
    Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: implications for surveillance studies and new adjuvant therapies.
    Chan EY; Larson AM; Fix OK; Yeh MM; Levy AE; Bakthavatsalam R; Halldorson JB; Reyes JD; Perkins JD
    Liver Transpl; 2008 Jul; 14(7):956-65. PubMed ID: 18581511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J; Xu Y
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver.
    Suda T; Isokawa O; Aoyagi Y; Nomoto M; Tsukada K; Shimizu T; Suzuki Y; Naito A; Igarashi H; Yanagi M; Takahashi T; Asakura H
    Hepatology; 1998 Feb; 27(2):402-6. PubMed ID: 9462637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.